-
UEFA's Ceferin tells Infantino to go, but 'not interested' in replacing him
-
Hyundai union back in wage talks after rare full-day strike
-
Oil falls as Trump pledges economic war on Iran
-
Shein grapples with EU backlash, but clients keep coming
-
Yamashita marches to nine-shot win in LPGA Canadian Women's Open
-
Key facts about Chinese-founded fast-fashion giant Shein
-
Gauff powers past Pegula to win US Open warm-up in Cincinnati
-
Shein to make market debut in Hong Kong in September
-
Japan's Olympic figure skating heroes to wed
-
Fils tops Tiafoe to claim first ATP Masters title in Cincinnati
-
Cummins eyes ODI return ahead of 'big' South Africa Test series
-
Gauff powers past Pegula to win Cincinnati WTA 1000 crown
-
India police used excessive force during protests: Amnesty
-
Ukraine backers gather as war escalates, air defence runs low
-
Rookie La Sasso wins LIV season-ender as tour's future in doubt
-
Syria says Israel talks addressed de-escalation, staying out of Israel-Turkey tensions
-
Fils tops Tiafoe to claim first ATP Masters title in Cincinnati bb/amz
-
Tourism boom pushes limits of Athens air traffic control
-
Clark fends off McIlroy to win BMW Championship
-
Liga holders Barcelona crush Elche, Atletico salvage Villarreal draw
-
Raphinha, Lopez hit braces as Barcelona trounce Elche
-
Spain's World Cup hero Torres saves PSG's blushes at Rennes
-
Macron hosts Saudi crown prince for visit ranging from esports to Mideast
-
Swiss forward Embolo joins Atlanta United
-
Jamieson gets Trump call after ending 14-year golf title drought
-
Former cricket captains appeal to Pakistan over Khan health care
-
Norwegian King Harald's health has 'deteriorated': palace
-
Latest 'Spider-Man' tops American box office for 4th weekend
-
Man City snatch late win in Maresca debut, Iraola's Liverpool rescue dramatic draw
-
Szoboszlai's last-gasp leveller rescues Liverpool in Newcastle draw
-
Trump takes starring role at Washington's IndyCar debut
-
Landfill collapse kills 30 in Guinea
-
Villa boss Emery says it's down to Watkins to explain absence
-
'Unbelievable' Cherki proves his point to Man City boss Maresca
-
Duplantis labours to 'super difficult' pole vault win at Silesia Diamond League
-
10-man Atletico snatch Villarreal draw as Alvarez returns
-
Max smash at zany Zandvoort: Three stories from the Dutch GP
-
Seville, Jefferson-Wooden roar to 100m wins at Silesia Diamond League
-
Brennan sprints to Vuelta stage two victory, Pogacar keeps red
-
VW chief warns carmaker's situation 'more than critical'
-
Duplantis conquers pole vault at Silesia Diamond League
-
England cricketer Carse under investigation after 'nightclub incident'
-
France's badminton gold winners set for obscurity back home
-
McLaren's Norris wins Dutch GP after Verstappen crash
-
Brighton start Premier League season with rout of 10-man Villa
-
Giroud scores as Lille give Davide Ancelotti winning start
-
Maresca makes winning start with Man City after dramatic fightback
-
Kejelcha smashes half-marathon world record in Buenos Aires
-
Mo'unga returns for All Blacks against Johannesburg Lions
-
Trump admin predicts US trade war 'devastating' for Canada
Nobel chemistry winner sees engineered proteins solving tough problems
Whether it's battling tumors or breaking down plastic, American scientist David Baker, co-recipient of this year's Nobel Prize in Chemistry, has an answer: engineering proteins that don't naturally exist -- a concept once dismissed as "crazy."
Today, proteins with novel functions are flowing steadily out of his lab, with an endless list of potential applications ranging from ultra-targeted therapies to the development of new vaccines.
"Across the range of problems that we face today in medicine and health, sustainability, energy, and technology, I think the potential for protein design is enormous," Baker told AFP via video call from Seattle, hours after learning of his Nobel win alongside two other laureates.
Proteins are organic molecules that play a fundamental role in almost every function of living organisms, from muscle contraction and food digestion to neuron activation and more.
"The ones in nature evolved to solve all the problems that were faced during natural selection," explained the 62-year-old University of Washington professor.
"But humans face new problems today," added the biochemist and computational biologist.
"We're heating up the planet, so we need new solutions in ecology and sustainability. We live longer, so there's new diseases which are relevant, like Alzheimer's disease. There's new pathogens like coronavirus."
Rather than leave these problems up to evolution -- a "brutal" solution that would take a very, very long time -- "with new proteins, we can solve those problems, but in a very short time," he said.
- From fringe to mainstream -
All proteins are composed of chains of amino acids, whose sequence dictates their shape -- and ultimately their function.
For decades, scientists have tried to determine protein structures based on these amino acid sequences.
In the late 1990s, Baker made strides towards solving this problem with a computer software he developed called Rosetta.
His success prompted a shift his focus to the reverse approach: starting with a desired shape and using Rosetta to identify the corresponding amino acid sequence. This sequence can then be introduced into bacteria, which synthesize the new protein that can be harvested and studied.
In 2003, he published his breakthrough finding -- the creation of the first-ever protein not found in nature -- though it still lacked a defined function.
"Then we started trying to design proteins that actually would do useful things," Baker recalled. "And that's when people, I think, really started thinking it was crazy."
But "for the last 20 years -— and really, most recently, the last five years -— we've been able to make proteins that do all kinds of amazing things," he said. Rosetta meanwhile has been progressively improved to incorporate artificial intelligence.
"I think what's kind of funny now is that the lunatic fringe, which pretty much no one was doing, has now entered the mainstream," he added with a laugh.
- Keys that fit locks -
How do scientists decide what shape a new protein needs to achieve the desired function?
Baker gives the example of a tumor. "We know some protein that's on the surface of that tumor, and we know its shape. What we do is we design a protein that acts like a key fitting into a lock," he explained.
Another application: breaking down plastic. In this case, a protein is designed to attach itself to the plastic molecule, accompanied by chemical compounds to "cut" it.
In medicine, this technology has already been used in a Covid-19 vaccine approved in South Korea. Researchers are also exploring its potential to create new materials.
"In biology, we have tooth and bone, we have shells, which are made by proteins interacting with inorganic compounds like calcium carbonate or calcium phosphate," says Baker, envisioning proteins interacting with other compounds to create entirely new materials with unique properties.
Greenhouse gas capture, a universal flu vaccine, improved antivenom -- Baker's wish list goes on and on.
"As protein design becomes more powerful, I'm incredibly excited about all the problems that we will be able to solve."
A.Mahlangu--AMWN